Ophthalmology And Visual Sciences

H. Culver Boldt, MD

Portrait

Marion and Frederick Fuerste, M.D. Professor of Ophthalmology
Director, Ocular Echography Service
Professor of Ophthalmology and Visual Sciences

Contact Information

Primary Office: 11196G  PFP
Iowa City, IA 52242
Primary Office Phone: 319-353-6112

Email: culver-boldt@uiowa.edu

Education

BS, Medical Education, Honors Program, Northwestern University, Chicago, IL
MD, Medicine, Northwestern University, Chicago, IL

Internship, Transitional, Evanston Hospital
Residency, Ophthalmology, University of Iowa
Fellowship, Echography, Sandra Frazier Byrne
Fellowship, Medical Retina, Wilmer Ophthalmological Institute
Fellowship, Vitreoretinal Surgery, Medical College of Wisconsin

Licensure and Certifications

State of Iowa Medical License, Iowa Board of Medicine
ABO Certification, American Board of Ophthalmology
NBME Diplomate, National Board of Medical Examiners

All Publications

Tozer K, Roller A, Chong L, Sadda S, Folk J, Mahajan V, Russell S, Boldt H, Sohn E.  Combination therapy for neovascular age-related macular degeneration refractory to anti-vascular endothelial growth factor agents.  Ophthalmology.  2013 May 25. 

Russell S, Sohn E, Boldt H, Folk J, Tarantola R, Kay C, Mahajan V.  Elimination of infusion bubbles and uncontrolled reflux in the Alcon Constellation Vitrectomy System.  Retina.  2013 April. 33(4):803-806.
[Link]

Cunningham M, Tarantola R, Folk J, Sohn E, Boldt H, Graff J, Elkins K, Russell S, Mahajan V.  Proliferative vitreoretinopathy may be a risk factor in combined macular hole retinal detachment cases.  Retina.  2013 March. 33(3):579-585.
[Link]

Scheetz T, Fingert J, Wang K, Kuehn M, Knudtson K, Alward W, Boldt H, Russell S, Folk J, Casavant T, Braun T, Clark A, Stone E, Sheffield V.  A genome-wide association study for primary open angle glaucoma and macular degeneration reveals novel Loci.  PLoS One;  2013.  Available from: http://dx.doi.org/10.1371/journal.pone.0058657

Bakall B, Folk J, Boldt H, Sohn E, Stone E, Russell S, Mahajan V.  Afibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.  Am J Ophthalmol.  2013. 156(1):15-22.
[PubMed]

Houston S, Boldt H, Markoe A, Murray T.  Brachytherapy for choroidal melanoma.  Saunders Elsevier.  2013. 

Cunningham M, Boldt H, Stone E.  Retinal detachment in a patient with Leber congenital amaurosis.  Retina Cases and Brief Reports.  2013. 7(1):102-104.

Tarantola R, Tsui J, Graff J, Russell S, Boldt H, Mahajan V, Folk J.  Intraoperative sclerotomy-related retinal breaks during 23-gauge pars plana vitrectomy.  Retina.  2013 January. 33(1):126-142.
[Link]

Skeie J, Brown E, Martinez H, Russell S, Birkholz E, Folk J, Boldt H, Gehrs K, Stone E, Wright M, Mahajan V.  Proteomic analysis of vitreous biopsy techniques.  Retina.  2012 December. 32(10):2141-2149.
[Link]

Davis A, Folk J, Russell S, Sohn E, Boldt H, Stone E, Mahajan V.  Intravitreal bevacizumab for peripapillary choroidal neovascular membranes.  Arch Ophthalmol.  2012 August. 130(8):1073-1075.
[Link]

Longmuir S, Dumitrescu A, Kwon Y, Boldt H, Hong S.  Juvenile xanthogranulomatosis with bilateral and multifocal ocular lesions of the iris, cornealscleral limbus, and choroid.  J AAPOS.  2011 December. 15(6):298-600.
[Link]

Roller A, Folk J, Patel N, Boldt H, Russell S, Abramoff M, Mahajan V.  Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.  Retina.  2011 October. 31(9):1848-1855.
[Link]

Houston 3rd S, Markoe A, Boldt H, Murray T.  Juxtapapillary uveal melanomas: patient outcomes after treatment with proton irradiation for peripapillary and parapapillary melanomas.  Arch Ophthalmol.  2011 September. 129(9):1218-1220.
[Link]

Kay C, Tarantola R, Gehrs K, Folk J, Mahajan V, Boldt H, Syed N, Russell S.  Uveitis following intravitreal bevacizumab: a non-infectious cluster.  Ophthalmic Surg Lasers Imaging.  2011 July. 42(4):292-296.
[Link]

Tarantola R, Folk J, Shah S, Boldt H, Abramoff M, Russell S, Mahajan V.  Intraoperative choroidal detachment during 23-gauge vitrectomy.  Retina.  2011 May. 31(5):893-901.
[Link]

Mahajan V, Tarantola R, Graff J, Boldt H, Abramoff M, Russell S, Folk J.  Sutureless triplanar sclerotomy for 23-gauge vitrectomy.  Arch Ophthalmol.  2011 May. 129(5):585-590.
[Link]

Mahajan V, Elkins K, Russell S, Boldt H, Gehrs K, Weingeist T, Stone E, Abramoff M, Liu D, Folk J.  Bilateral intravitreal injection of antivascular endothelial growth factor therapy.  Retina.  2011 January. 31(1):31-35.
[Link]

Longmuir S, Syed N, Boldt H.  Diffuse anterior retinoblastoma without retinal involvement.  Ophthalmology.  2010 October. 117(10):2034-8.
[Link]

Tarantola R, Folk J, Boldt H, Mahajan V.  Intravitreal bevacizumab during pregnancy.  Retina.  2010 October. 30(9):1405-1411.
[Link]

Roller A, Mahajan V, Boldt H, Abramoff M, Russell S, Folk J.  Effects of vitrectomy on age-related macular degeneration..  Ophthalmology.  2010 July. 117(7):1381-1386.
[Link]

Ying G, Maguire M, Alexander J, Martin R, Antoszyk A, The Complications of Age-related Macular Degeneration Prevention Trial Research Group, et al , Boldt H.  Description of the age-related eye disease study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial.  Arch Ophthalmol.  2009 September. 127(9):1147-1151.
[Link]

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, et al , Boldt H.  Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005.  Arch Intern Med.  2009 July 27. 169(14):1307-1316.
[Link]

Diabetes Control and Complications Trial/epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group , Boldt H.  Modern day clinical course of Type 1 diabetes mellitus. The diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) and Pittsburgh epidemiology of diabetes complications (EDIC) experience.  Arch Int Med.  2009 July. 169(Jul):1307-1316.
[Link]

Penson D, Wessells H, Cleary P, Rutledge B, Diabetes Control and Complications Trial/epidemiology of Diabetes Interventions and Complications Research Group , Boldt H.  Sexual dysfunction and symptom impact in men with long standing Type 1 diabetes in the DCCT/EDIC cohort.  Journal of Sexual Medicine.  2009 July. 6(7):1969-1978.
[Link]

Rauen M, Oetting T, Boldt H, Kwon Y.  Two non-infectious forms of endophthalmitis after intravitreal triamcinolone and cataract extraction.  Eye (Lond).  2009 July. 23(7):1611-1612.
[Link]

The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Intervention and Complications (EDIC) Research Group, et al , Boldt H.  Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).  Circulation.  2009 June 9. 119(22):2886-2893.
[Link]

Pop-Busui R, Low P, Waberski B, Martin C, Albers J, Feldman E, Sommer C, Cleary P, Lachin J, Herman W, DCCT/EDIC Research Group , Boldt H.  Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in Type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC).  Circulation.  2009 June. 119(22):2886-2893.
[Link]

Sarma A, Kanaya A, Nyberg L, Kusek J, Vittinghoff E, Rutledge B, Cleary P, Gatcomb P, Brown J, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group , Boldt H.  Risk factors for urinary incontinence among women with Type 1 diabetes: Findings from the epidemiology of diabetes interventions and complications (EDIC) Study.  Urology.  2009 June. 73(73):1203-1209.
[Link]

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, et al , Boldt H.  Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study.  Urology.  2009 June. 73(6):1203-1209.
[Link]

Enzlin P, Rosen R, Wiegel M, Brown J, Wesselis H, Gatcomb P, Rutledge B, Chan K, Cleary P, DCCT/EDIC Research Group , Boldt H.  Sexual dysfunction in women with Type 1 diabetes: Long-term findings from the DCCT/EDIC study cohort.  Diabetes Care.  2009 May. 32(5):780-785.
[Link]

Boldt H, Mahajan V, Folk J.  A head-tilt test for hypopyon after intravitreal triamcinolone.  Retina.  2009 April. 29(4):560-561.
[Link]

Van Den Eeden S, Sarma A, Rutledge B, Cleary z, Kusek J, Nyberg L, McVary K, Wessells H, Diabetes Control and Complications Trial/Epidemiology of Diabetes Research Group , Boldt H.  Effect of intensive glycemic control and diabetic complications on lower urinary tract symptoms (LUTS) in men with Type 1 diaetes: Diabetes control and complications trial (DCCT/Epieemiology fo diabetes interventions and complications (DCCT/EDIC) study.  Diabetes Care.  2009 April. 32(4):664-670.
[Link]

Sarma A, Kanaya A, Nyberg L, Kusek J, Vittinghoff E, Rutledge B, Cleary P, Gatcomb P, Brown J, Diabetes Control and Complications Trial/epidemiology of Diabetes Interventions and Complications Research Group , Boldt H.  Urinary incontinence among women with Type 1 diabetes: How common is it?.  Journal of Urology.  2009 March. 181(3):1224-1230.
[Link]

Czaja C, Rutledge B, Cleary P, Chan K, Stapleton A, Stamm W, Diabetes Control and Complications Trial/Epidemiology of Diabetes Inverventions and Complications Research Group , Boldt H.  Urinary tract infections in women with Type 1 diabetes mellitus: Survey of female participants in the epidemioloy of diabetes interventions and complications study cohert.  Journal of Urology.  2009 March. 181(3):1134-1135.
[Link]

Delahanty L, Nathan D, Lachin J, Hu F, Cleary P, Ziegler G, Wylie-Rosett J, Wexler D, Diabetes Control and Complications Trial/Epidemiology of Diabetes Research Group , Boldt H.  Association of diet with glycated hemoglobin during intensive treatment of Type 1 diabetes i nthe control and complicatins trial.  American Journal of Clinical Nutrition.  2009 February. 89(2):518-524.
[Link]

 .  Cardiac autonomic neuropathy in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study (EDIC/DCCT) trial.  Circulation.  2009. 119:2886-2893.

Boldt H, Melia B, Liu J, Reynolds S.  I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS Report No. 30.  Ophthalmology.  2009 January. 116(1):106-115.e1.
[Link]

White N, Sun W, Cleary P, Danis R, Davis M, Hainsworth D, Hubbard L, lachin J, Nathan D, The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC Research Group , Boldt H.  Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with Type 1 diabetes mellitus: 10 years after the DCCT.  Arc Ophthalmol.  2008 December. 126(12):1707-1715.
[Link]

Musen G, Jaconbson A, Ryan C, Cleary P, Waberski B, Weinger K, Dahms W, Bayliss M, Silvers N, Harth J, White N, Diabetes Control and Complications Trial?Epidemiology of Diabetes Inverventions and Complications Research Group , Boldt H.  The impact of diabetes and its treatment on cognitive function among adolescents who participated in the DCCT.  Diabetes Care.  2008 October. 31(10):1933-1938.
[Link]

Boldt H, Byrne S, Gilson M, Finger P, Green R, Straatsma B, Simpson E, Hawkins B.  Baseline echographic characteristics of tumors in eyes of patients enrolled in the Collaborative Ocular Melanoma Study: COMS report no. 29.  Ophthalmology.  2008 August. 115(8):1390-7, 1397.e1-2.
[Link]

Lachin J, Genuth S, Nathan D, Zinman B, Rutledge B, DCCT/EDIC Research Group , Boldt H.  Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial-revisited.  Diabetes.  2008 April. 57(4):995-1001.
[Link]

Lee A, Golnik K, Oetting T, Beaver H, Boldt H, Olson R, Greenlee E, Abramoff M, Johnson A.  Re-engineering the resident applicant selection process in ophthalmology: a literature review and recommendations for improvement.  Surv Ophthalmol.  2008 March. 53(2):164-176.
[Link]

Abràmoff M, Folk J, Lee A, Beaver H, Boldt H.  Teaching and assessing competency in retinal lasers in ophthalmology residency.  Ophthalmic Surg Lasers Imaging.  2008. 39(4):270-80.
[Link]

Boldt H, Murray T.  Tumor involvement of the vitreous.  Saunders Elsevier.  2008. 

Lee A, Beaver H, Greenlee E, Oetting T, Boldt H, Olson R, Abramoff M, Carter K.  Teaching and assessing systems-based competency in ophthalmology residency training programs..  Surv Ophthalmol.  2007 December. 52(6):680-689.
[Link]

Carter R, Lackland D, Cleary P, Yim E, Lopes-Virella M, Gilbert G, Orchard T, Diabetes Control and Complications Trial/Epidemiology of Diabetes interventins and Complications (DCCT/EDIC Study Research Group , Boldt H.  Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in diabetes control and complications trial.  Diabetes Care.  2007 October. 30(10):2646-2648.
[Link]

Albers J, Herman W, Pop-Busui R, Martin C, Cleary P, Waberski B, Diabetes Control and Complications Trial (DCCT/Epidemiology of Diabetes Invervention and Complications (EDIC) Research Group , Boldt H.  Subclinical neuropathy among diabetes control and complications trial participants without diagnosable neuropathy at trial completion.  Diabetes Care.  2007 October. 30(10):2613-2618.
[Link]

Paterson A, Rutledge B, Cleary P, Lachin J, Crow R, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group , Boldt H.  The effect of intensive diabetes treatment on resting heart rate in Type 1 diabetes: The diabetes control and complications trial/epidemiology of diabetes interventions and complications study.  Diabetes Care.  2007 August. 30(8):2107-2112.
[Link]

Lee A, Greenlee E, Oetting T, Beaver H, Johnson A, Boldt H, Abramoff M, Olson R, Carter K.  Assessing cataract surgical competency.  Ophthalmology.  2007 July. 114(7):1415-1416.
[Link]

Lee A, Greenlee E, Oetting T, Beaver H, Johnson A, Boldt H, Abramoff M, Olson R, Carter K.  The Iowa ophthalmology wet laboratory curriculum for teaching and assessing cataract surgical competency.  Ophthalmology.  2007 July. 114(7):e21-6.
[Link]

Lee A, Beaver H, Boldt H, Olson R, Oetting T, Abramoff M, Carter K.  Teaching and assessing professionalism in ophthalmology residency training programs..  Surv Ophthalmol.  2007 June. 52(3):300-314.
[Link]

The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC Study Research Group , Boldt H.  Long-term effect of diabetes and its treatment on cognitive function.  New Engl J Med.  2007. 356:1842-1852.

Cleary P, Orchard T, Genuth S, Wong N, Detrano R, Backlund J, Zinman B, Jacobson A, Sun W, Lachin J, Nathan D, DCCT/EDIC Research Group , Boldt H.  The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.  Diabetes.  2006 December. 55(12):3556-3565.
[Link]

Oetting T, Lee A, Beaver H, Johnson A, Boldt H, Olson R, Carter K.  Teaching and assessing surgical competency in ophthalmology training programs.  Ophthalmic Surg Lasers Imaging.  2006 October. 37(5):384-393.
[Link]

Boldt H.  Posterior segment tumors: the latest in current management.  Retina.  2006 August. 26(6 Suppl):S37-S44.
[Link]

Zumbro D, Sanders J, Boldt H, Novack R, Dugel O, Klein M.  Diagnostic and therapeutic challenges.  Retina.  2006 May. 26(5):571-577.
[Link]

Lee A, Boldt H, Golnik K, Arnold A, Oetting T, Beaver H, Olson R, Zimmerman M, Carter K.  Structured journal club as a tool to teach and assess resident competence in practice-based learning and improvement.  Ophthalmology.  2006 March. 113(3):497-500.
[Link]

Wendel L, Lee A, Boldt H, Kardon R, Wall M.  Subretinal neovascular membrane in idiopathic intracranial hypertension.  Am J Ophthalmol.  2006 March. 141(3):573-574.
[Link]

Martin C, Albers J, Herman W, Cleary P, Waberski B, Greene D, Stevens M, Feldman E, DCCT/EDIC Research Group , Boldt H.  Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.  Diabetes Care.  2006 February. 29(2):340-344.
[Link]

Shah V, Randhawa S, Boldt H, Lee A.  Central serous chorioretinopathy in giant cell arteritis.  Semin Ophthalmol.  2006. 21(1):45-8.
[Link]

Complications of Age-Related Macular Degeneration Prevention Trial Research Group , Boldt H.  Laser treatment in patients with bilateral large drusen: The complications of age-related macular degeneratin prevention trial.  Ophthalmology.  2006. 113:1974-1986.

Nathan D, Cleary P, Backlund J, Genuth S, Lachin J, Orchard T, Raskin P, Zinman B, DCCT/EDIC Research Group , Boldt H.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.  N Engl J Med.  2005 December. 353(25):2643-2653.
[Link]

Lee A, Boldt H, Golnik K, Arnold A, Oetting T, Beaver H, Olson R, Carter K.  Using the Journal Club to teach and assess competence in practice-based learning and improvement: a literature review and recommendation for implementation.  Surv Ophthalmol.  2005 December. 50(6):542-548.
[Link]

Kwon Y, Rickman D, Baruah S, Zimmerman M, Kim C, Boldt H, Russell S, Hayreh S.  Reply to: Glutamate excitotoxicity in glaucoma: throwing the baby out with the bathwater? .  Eye advance online publcation.  2005 June 10. 

Steffes M, Cleary P, Goldstein D, Little R, Wiedmeyer H, Rohlfing C, England J, Bucksa J, Nowicki M, DCCT/EDIC Research Group , Boldt H.  Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.  Clin Chem.  2005 April. 51(4):153-158.
[Link]

Kwon Y, Rickman D,  S, Zimmerman M, Kim C, Boldt H, Russell S, Hayreh S.  Vitreous and retinal amino acid concentrations in experimental central retinal artery occlusion in the primate..  Eye (Lond).  2005 April. 19(4):455-463.
[Link]

The DCCT/EDIC Research Group , Boldt H.  Glycated hemoglobin (HbA1c) measurements over nearly two decades: Sustaining comparable values throughout the diabetes control and complications trial and the epidemiology of diabtes interventions and complications study.  Clin Chem.  2005. 51:753-758.

The DCCT/EDIC Research Group , Boldt H.  Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with Type 1 diabetes.  Diabetes.  2005. 54:3103-3111.

Lee A, Boldt H.  Optical coherence tomography in neuro-ophthalmology.  Transactions of the 54th annual symposium of the New Orleans Academy of Ophthalmology.  2005. 

Boldt H.  Tumor diagnosis, therapies improve over past 20 years: Better therapies needed for micrometastatic melanoma and advanced retinoblastoma.  Ophthalmology Times.  2005. 30:30.

Liu J, Boldt H, Folk J, Gehrs K.  Photodynamic therapy of subfoveal and juxtafoveal choroidal neovascularization in ocular histoplasmosis syndrome: a retrospective case series.  Retina.  2004 December. 24(6):863-70.
[Link]

Hawkins B, Collaborative Ocular Melanoma Study Group , Boldt H.  The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.  Am J Ophthalmol.  2004 December. 138(6):936-951.
[Link]

Collaborative Ocular Melanoma Study Group , Boldt H.  Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.  Ophthalmology.  2004 May. 11(5):966-976.
[Link]

Coleman D, Silverman R, Rondeau M, Boldt H, Lloyd H, Lizzi F, Weingeist T, Chen X, Vangveeravong S, Folberg R.  Noninvasive in vivo detection of prognostic indicators for high-risk uveal melanoma: ultrasound parameter imaging.  Ophthalmology.  2004 March. 111(3):558-64.
[Link]

DCCT/EDIC Research Group , Boldt H.  Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.  JAMA.  2003 October. 290(16):2159-2167.
[Link]

Collaborative Ocular Melanoma Study Goup , Boldt H.  Comparison of clinical, echographic, and histopathological measurements from eyes with medium-sized choroidal melanoma in the collaborative ocular melanoma study: COMS report no. 21.  Arch Ophthalmol.  2003 August. 121(8):1163-1171.
[Link]

Collaborative Ocular Melanoma Study Group , Boldt H.  Trends in size and treatment of recently diagnosed choroidal melanoma, 1987-1997: findings from patients examined at collaborative ocular melanoma study (COMS) centers: COMS report no. 20.  Arch Ophthalmol.  2003 August. 121(8):1156-1162.
[Link]

Silverman R, Folberg R, Rondeau M, Boldt H, Lloyd H, Chen X, Lizzi F, Weingeist T, Coleman D.  Spectral parameter imaging for detection of prognostically significant histologic features in uveal melanoma.  Ultrasound Med Biol.  2003 July. 29(7):951-9.
[Link]

Nathan D, Lachin J, Cleary P, Orchard T, Brillon D, Backlund J, O'Leary D, Genuth S, DCCT/EDIC Research Group , Boldt H.  Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.  N Engl J Med.  2003 June. 348(23):2294-2303.
[Link]

Honkanen R, Baruah S, Zimmerman M, Khanna C, Weaver Y, Narkiewicz J, Waziri R, Gehrs K, Weingeist T, Boldt H, Folk J, Russell S, Kwon Y.  Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy.  Arch Ophthalmol.  2003 February. 121(2):183-188.
[Link]

Chew E, Benson W, Boldt H, Chang T, Lobes L, Miller J, Murray T, Zarbin M, Hyman L.  Age-related macular degeneration.  American Academy of Ophthalmology.  2003. 

Margolis R, Rondeau M, Silberman R, Folberg R, Boldt H, Coleman D, Lizzi F.  Alternative scattering models for ultrasound parameter imaging of ocular tumors.  Ultrasound Med Biol.  2003. 29(5 Supplement):S98.

Boldt H, The Anecortave Acetate Clinical Study Group .  Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): Interim (month 6) analysis of clinical safety and efficacy.  Retina.  2003. 23:14/23.

Boldt H, The Anecortave Acetate Clinical Study Group .  Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macualr degeneration: twelve-month clinical outcomes.  Ophthalmology.  2003. 110:2372-2385.

Murray T, Hayden B, Boldt H, Moy C.  Clinical trials in uveal melanoma: Patient characteristics and the treatment of intraocular tumors.  Marcel Dekker, Inc..  2003. 

Chew E, Benson W, Boldt H, Chang T, Lobes L, Miller J, Murray T, Zarbin M, Hyman L.  Diabetic retinopathy.  American Academy of Ophthalmology.  2003. 

Chew E, Benson W, Boldt H, Chang T, Lobes L, Miller J, Muray T, Zarbin M, Hyman L.  Idiopathic macular hole.  American Academy of Ophthalmology.  2003. 

Boldt H, The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group .  Intensive diabetes therapy and carotid intima-media thickness in Type 1 diabetes mellitus.  N Eng J Med.  2003. 348:2294-2303.

Boldt H, Choroidal Neovascularization Prevention Trial Research Group .  Laser treatment in fellow eyes with large drusen: Updated findings from a pilot randomized clinical trial.  Ophthalmology.  2003. 110:971-978.

Velez G, Boldt H, Whitcup S, Nussenblatt R, Robinson M.  Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.  Ophthalmic Surg Lasers.  2003. 33(4):329-333.

Chew E, Benson W, Boldt H, Chang T, Lobes L, Miller J, Murray T, Zarbin M, Hyman L.  Posterior vitreous detachment, retinal breaks, and lattice degeneration.  Preferred Practice Patterns, American Academy of Ophthalmology.  2003. 

Velez G, Boldt H, Whitcup S, Nussenblatt R, Robinson M.  Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.  Ophthalmic Surg Lasers.  2002 July. 33(4):329-333.
[Link]

DCCT/EDIC Research Group , Boldt H.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.  JAMA.  2002 May. 287(19):2563-2569.
[Link]

Byrne S, Marsh M, Boldt H, Green R, Johnson R, Wilson D.  Consistency of observations from echograms made centrally in the Collaborative Ocular Melanoma Study COMS Report No. 13.  Ophthalmic Epidemiol.  2002 February. 9(1):11-27.
[Link]

White N, Cleary P, Dahms W, Goldstein D, Malone J, Tamborlane W, DCCT/EDIC Research Group , Boldt H.  Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT)..  J Pediatr.  2001 December. 139(6):804-812.
[Link]

Diener-West M, Earle J, Fine S, Hawkins B, Moy C, Reynolds S, Schachat A, Straatsma B, Collaborative Ocular Melanoma Study Group , Boldt H.  The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17.  Arch Ophthalmol.  2001 July. 119(7):951-965.
[Link]

Diener-West M, Earle J, Fine S, Hawkins B, Moy C, Reynolds S, Schachat A, Straatsma B, Collaborative Ocular Melanoma Study Group , Boldt H.  The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18.  Arch Ophthalmol.  2001 July. 119(7):969-982.
[Link]

Moy C, Albert D, Diener-West M, McCaffrey L, Scully R, Willson J, Collaborative Ocular Melanoma Study Group , Boldt H.  Cause-specific mortality coding: Methods in the collaborative ocular melanoma study: COMS report no. 14.  Control Clin Trials.  2001 June. 22(3):248-262.
[Link]

Collaborative Ocular Melanoma Study Group , Boldt H.  Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15.  Arch Ophthalmol.  2001 May. 119(5):670-676.
[Link]

Folberg R, Chen X, Boldt H, Pe'er J, Brown C, Woolson R, Maniotis A.  Microcirculation patterns other than loops and networks in choroidal and ciliary body melanomas.  Ophthalmology.  2001 May. 108(5):996-1001.
[Link]

Johnson R, McDonald H, Lewis H, Grand M, Murray T, Mieler W, Johnson M, Boldt H, Olsen K, Tornambe P, Folk J.  Traumatic macular hole: observations, pathogenesis, and results of vitrectomy surgery.  Ophthalmology.  2001 May. 108(5):853-7.
[Link]

Melia B, Abramson D, Albert D, Boldt H, Earle J, Hanson W, Montague P, Moy C, Schachat A, Simpson E, Straatsma B, Vine A, Weingeist T, Collaborative Ocular Melanoma Study Group .  Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.  Ophthalmology.  2001 February. 108(2):348-366.
[Link]

Boldt H, The DCCT Research Group .  Influence of intensive diabetes treatment on body weight and composition of adults with Type 1 diabetes in the Diabetes Control and Complications Trial.  Diabetes Care.  2001. 24:1711-1721.

Boldt H.  Sturge-Weber syndrome.  Lippincott Williams & Wilkins.  2001. 

Boldt H, Schachat A.  Tumor involvement of the vitreous cavity.  Mosby.  2001. 

DCCT Research Group , Boldt H.  Effect of pregnancy on microvascular complications in the diabetes control and complications trial.  Diabetes Care.  2000 August. 23(8):1084-1091.
[Link]

DCCT/EDIC Research Group , Boldt H.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.  N Engl J Med.  2000 February. 342(6):381-389.
[Link]

Boldt H.  Diagnostic and therapeutic challenges.  Retina.  2000. 20:537-538.

Oh K, Boldt H, Maturi R, Folk J, Kardon R.  Evaluation of patients with visual field defects following macular hole surgery using multifocal electroretinography.  Retina.  2000. 20(3):238-43.
[Link]

Charukamnoetkanok P, Johnson A, Boldt H.  Purtcher's-like retinopathy associated with acute pancreatitis.  Middle East Journal of Ophthalmology.  2000. 8:52054.

Aaberg, Jr. T, Boldt H, Murray T.  Uveal malignant melanoma.  Butterworth-Heinemann.  2000. 

Collaborative Ocular Melanoma Study Group , Boldt H.  Echography (Ultrasound) Procedures for the Collaborative Ocular Melanoma Study (COMS), Report no. 12, Part II.  J Ophthalmic Nurs Technol.  1999 September. 18(5):219-232.
[Link]

Collaborative Ocular Melanoma Study Group , Boldt H.  Echography (ultrasound) procedures for the Collaborative Ocular Melanoma Study (COMS), Report no. 12, Part I.  J Ophthalmic Nurs Technol.  1999 July. 18(4):143-149.
[Link]

Collaborative Ocular Melanoma Study Group , Boldt H.  Echography (ultrasound procedures for the collaborative ocular melanoma study (COMS). COMS Report No. 12, Part II.  Journal of Ophthamlic Nursing & Technology.  1999 May. 18(5):219-232.

Collaborative Ocular Melanoma Study Group , Boldt H.  Echography (ultrasound) procedures for the collaborative ocular melanoma study (COMS). COMS Report No 12, Part I.  Journal of Ophthalmic Nursing & technology.  1999 April. 18(4):143-149.

EDIC Research Group , Boldt H.  Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.  Diabetes.  1999 February. 48(2):383-390.
[Link]

EDIC Research Group , Boldt H.  Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.  Diabetes Care.  1999 January. 22(1):99-111.
[Link]

Folk J, Boldt H, Keenum D.  Foveal cysts: a premacular hole condition associated with vitreous traction.  Arch Ophthalmol.  1998 September. 116(9):1177-83.
[Link]

Collaborative Ocular Melanoma Study Group , Boldt H.  The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma III: local complications and observations following enucleation COMS report no. 11.  Am J Ophthalmol.  1998 September. 126(3):362-371.
[Link]

Collaborative Ocular Melanoma Study Group , Boldt H.  Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS report no. 6.  Am J Ophthalmol.  1998 June. 125(6):745-766.
[Link]

Collaborative Ocular Melanoma Study Group , Boldt H.  The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled. COMS report no. 9.  Am J Ophthalmol.  1998 June. 125(6):767-778.
[Link]

Collaborative Ocular Melanoma Study Group , Boldt H.  The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10.  Am J Ophthalmol.  1998 June. 125(6):779-796.
[Link]

Hendrix M, Seftor E, Seftor R, Kirschmann D, Gardner L, Boldt H, Meyer M, Pe'er J, Folberg R.  Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).  Am J Pathol.  1998 April. 152(4):855-63.
[Link]

Oh K, Polk T, Boldt H, Turner J.  Systemic small noncleaved cell lymphoma presenting as a posterior choroidal mass.  Am J Ophthalmol.  1998 April. 125(4):560-2.
[Link]

Hendrix M, Seftor E, Seftor R, Gardner L, Boldt H, Meyer M, Pe'er J, Folberg R.  Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.  Lab Invest.  1998 February. 78(2):153-163.
[Link]

The Choroidal Neovascularization Prevention Trial Research Group , Boldt H.  Laser treatment in eyes with large drusen: Short-term effects seen in a pilot randomized clinical trial.  Ophthalmology.  1998. 105:11-23.

Boldt H, Munden P, Folk J, Mehaffey M.  The magnitude of the bubble buoyant pressure: Implications for macular hole surgery [response].  Retina.  1998. 18:86-87.

Folk J, Boldt H.  What happens to untreated asymptomatic retinal breaks, and are the affected by posterior vitreous detachment [discussion].  Ophthalmology.  1998. 105:1049-1050.

Mueller A, Bartsch D, Folberg R, Mehaffey M, Boldt H, Meyer M, Gardner L, Goldbaum M, Pe'er J, Freeman W.  Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy.  Arch Ophthalmol.  1998 January. 116(1):31-9.
[Link]

Collaborative Ocular Melanoma Study Group , Boldt H.  Factors predictive of growth and treatment of small choroidal melanoma: The Collaborative Ocular Melanoma Study Group: COMS Report no. 5.  Arch Ophthalmol.  1997 December. 115(12):1537-1544.
[Link]

Oh K, Boldt H, Danis R.  Iatrogenic central retinal vein occlusion and hyperviscosity associated with high-dose intravenous immunoglobulin administration.  Am J Ophthalmol.  1997 September. 124(3):416-8.
[Link]

Grossniklaus H, Albert D, Green W, Conway B, Hovland K, Collaborative Ocular Melanoma Study , Boldt H.  Clear cell differentiation in choroidal melanoma: The Collaborative Ocular Melanoma Study Group: COMS report no. 8.  Arch Ophthalmol.  1997 July. 115(7):894-898.
[Link]

Collaborative Ocular Melanoma Study Group , Boldt H.  Mortality in patients with small choroidal melanoma: The Collaborative Ocular Melanoma Study Group: COMS report no. 4.  Arch Ophthalmol.  1997 July. 115(7):886-893.
[Link]

Park D, Boldt H, Massicotte S, Akang E, Roos K, Bodnar A, Pless J, Ghetti B, Pascuzzi R.  Subacute sclerosing panencephalitis manifesting as viral retinitis: clinical and histopathologic findings.  Am J Ophthalmol.  1997 April. 123(4):533-42.
[Link]

Silverman R, Folberg R, Boldt H, Lloyd H, Rondeau M, Mehaffey M, Lizzi F, Coleman D.  Correlation of ultrasound parameter imaging with microcirculatory patterns in uveal melanomas.  Ultrasound Med Biol.  1997. 23(4):573-81.
[Link]

Murray T, Steeves R, Gentry L, Bresnick G, Boldt H, Mieler W, Tompkins D.  Ferromagnetic hyperthermia: functional and histopathologic effects on normal rabbit ocular tissue.  Int J Hyperthermia.  1997. 13(4):423-36.
[Link]

Pharmacological Therapy for Macular Degeneration Study Group , Boldt H.  Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration.  Arch Ophthalmol.  1997. 115:865-872.

Boldt H, Mieler W.  Endophthalmitis.  Little, Brown and Company.  1996. 

Daniels K, Boldt H, Martin J, Gardner L, Meyer M, Folberg R.  Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression.  Lab Invest.  1996. 75(1):55-66.
[Link]

Boone D, Boldt H, Ross R, Folk J, Kimura A.  The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model.  Retina.  1996. 16(6):518-24.
[Link]

Boldt H, Munden P, Folk J, Mehaffey M.  Visual field defects after macular hole surgery.  Am J Ophthalmol.  1996. 122(3):371-381.
[Link]

Keenum D, Boldt H, Byrne S.  Modern diagnostic techniques in the evaluation of ocular trauma.  Ophthalmol Clin North America.  1995. 8:589-608.

Boldt H.  Ocular sequelae of blunt trauma.  Ophthalmology World News.  1995. 1:20-21, 26.

Boldt H, Brown D, McGeorge A.  Echographic diagnosis of degenerative retinoschisis facilitated by scleral indentation.  Am J Ophthalmol.  1994 July. 118(1):123-124.
[Link]

Han D, Nanda S, O'Brien W, Guy J, Murray T, Boldt H.  Evaluation of anterior segment tolerance to short-term intravitreal perfluoron.  Retina.  1994. 14(3):219-224.
[Link]

Han D, Wang Q, Hartz A, Jaffe G, Murray T, Boldt H, Arrindell E, Coe E, Abrams G, Mieler W.  Postoperative fibrin formation and visual outcome after pars plana vitrectomy.  Retina.  1994. 14(3):225-30.
[Link]

Collaborative Ocular Melanoma Study Group , Boldt H.  Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study. COMS Report No. 3.  Control Clin Trials.  1993 October. 14(5):362-391.
[Link]

Danis R, Yang Y, Massicotte S, Boldt H.  Preretinal and optic nerve head neovascularization induced by photodynamic venous thrombosis in domestic pigs.  Arch Ophthalmol.  1993 April. 111(4):539-543.
[Link]

Collaborative Ocular Melanoma Study Group , Boldt H.  Complications of enucleation surgery:COMS Report No. 2.  Kugler.  1993. 

Steeves R, Murray T, Moros E, Boldt H, Mieler W, Paliwal B.  Concurrent ferromagnetic hyperthermia and 125I brachytherapy in a rabbit choroidal melanoma model.  Int J Hyperthermia.  1992 July. 8(4):443-449.
[Link]

Boldt H, Abrams G, Murray T, Han D, Mieler W.  The lowest effective dose of tissue plasminogen activator for fibrinolysis of postvitrectomy fibrin.  Retina.  1992. 12(3 Suppl):S75-S79.
[Link]

Murray T, Boldt H, Lewis H, Abrams G, Mieler W, Han D.  A technique for facilitated visualization and dissection of the vitreous base, pars plana, and pars plicata.  Arch Ophthalmol.  1991 October. 109(10):1458-1459.
[Link]

Boldt H, Byrne S, DiBernardo C.  Echographic evaluation of optic disc drusen.  J Clin Neuroophthalmol.  1991 June. 11(2):85-91.
[Link]

Nichols C, Boldt H, Mieler W, Han D, Olsen K.  Ocular injuries caused by elastic cords.  Arch Ophthalmol.  1991 March. 109(3):371-372.
[Link]

Boldt H, Schachat A.  Ophthalmic manifestations of leukemia.  Medical Books.  1991. 

Collaborative Ocular Melanoma Study Group , Boldt H.  Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1.  Arch Ophthalmol.  1990 September. 108(9):1268-1273.
[Link]

Boldt H, Bressler S, Fine S, Bressler N.  Age-related macular degeneration.  Current Opinion in Ophthalmology.  1990. 1:247-257.

Folk J, Bennett S, Klugman M, Arrindell E, Boldt H.  Prophylactic treatment to the fellow eye of patients with phakic lattice retinal detachment: analysis of failures and risks of treatment.  Retina.  1990. 10(3):165-169.
[Link]

Boldt H, Folk J.  Slow leakage from the retinal pigment epithelium (ooze) in age-related macular degeneration.  Retina.  1990. 10(4):244-250.
[Link]

Boldt H, Pulido J, Blodi C, Folk J, Weingeist T.  Rural endophthalmitis.  Ophthalmology.  1989 December. 96(2):1722-1726.
[Link]

Boldt H, Nerad J.  Orbital metastases from prostate carcinoma.  Arch Ophthalmol.  1988 October. 106(10):1403-8.
[Link]

Owsley C, Sekuler R, Boldt H.  Aging and low-contrast vision: face perception.  Invet Ophthalmol Vis Sci.  1981 August. 21(2):362-365.
[Link]

Date Last Modified: 07/31/2013 - 10:51:40